Zerlasiran

Zerlasiran is an investigational new drug that is being evaluated to treat atherosclerotic cardiovascular disease.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Zerlasiran is an investigational new drug that is being evaluated to treat atherosclerotic cardiovascular disease. It is small interfering RNA (siRNA) drug candidate designed to reduce levels of lipoprotein(a).

Text derived from https://en.wikipedia.org/w/index.php?oldid=1362353093 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.